Physician profile
Michael P Schaelling
NPI 1861478737
$7,520.29
in general payments reported to CMS, 2019-2025
56 companies · $837 in 2025
The $837 reported for 2025 was more than what 83% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,173 · 2020: $709 · 2021: $1,110 · 2022: $1,192 · 2023: $1,230 · 2024: $1,269 · 2025: $837.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,337.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,336.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,394.05 | 2020-2025 | Vraylar, Ubrelvy, Qulipta |
| Novo Nordisk INC | $858.76 | 2019-2025 | Wegovy, Ozempic, Rybelsus |
| Glaxosmithkline, LLC. | $638.04 | 2019-2025 | Shingrix, Arexvy, Bexsero |
| Lilly USA, LLC | $394.47 | 2019-2025 | Mounjaro, Zepbound, Trulicity |
| Amgen INC. | $381.74 | 2019-2025 | Evenity, Prolia |
| Pfizer INC. | $349.20 | 2019-2025 | |
| Allergan, INC. | $331.12 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $324.70 | 2019-2025 | Jardiance |
| Abbott Laboratories | $248.93 | 2021-2025 | Freestyle Libre 3, Freestyle Libre 2 |
| Janssen Pharmaceuticals, INC | $241.26 | 2019-2025 | Spravato |
| Dynavax Technologies Corporation | $224.48 | 2019-2025 | Heplisav-B |
| Astellas Pharma US INC | $205.83 | 2019-2025 | Veozah |
| Amarin Pharma, INC. | $163.56 | 2019-2022 | |
| Corium, LLC | $118.43 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $112.20 | 2019-2025 | Airsupra, Farxiga, Breztri |
Show all 56 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Schaelling listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.